PMID- 34618462 OWN - NLM STAT- MEDLINE DCOM- 20220225 LR - 20220225 IS - 1535-3907 (Electronic) IS - 1535-3893 (Linking) VI - 20 IP - 11 DP - 2021 Nov 5 TI - Salivary Metabolomics Reveals that Metabolic Alterations Precede the Onset of Schizophrenia. PG - 5010-5023 LID - 10.1021/acs.jproteome.1c00504 [doi] AB - Schizophrenia is a complex and highly heterogeneous mental illness with a prodromal period called clinical high risk (CHR) for psychosis before onset. Metabolomics is greatly promising in analyzing the pathology of complex diseases and exploring diagnostic biomarkers. Therefore, we conducted salivary metabolomics analysis in 83 first-episode schizophrenia (FES) patients, 42 CHR individuals, and 78 healthy controls with ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. The mass spectrometry raw data have been deposited on the MetaboLights (ID: MTBLS3463). We found downregulated aromatic amino acid metabolism, disturbed glutamine and nucleotide metabolism, and upregulated tricarboxylic acid cycle in FES patients, which existed even in the CHR stage and became more intense with the onset of the schizophrenia. Moreover, differential metabolites can be considered as potential diagnostic biomarkers and indicate the severity of the different clinical stages of disease. Furthermore, three disordered pathways were closely related to peripheral indicators of inflammatory response, oxidative stress, blood-brain barrier damage, and salivary microbiota. These results indicate that the disorder of oral metabolism occurs earlier than the onset of schizophrenia and is concentrated and intensified with the onset of disease, which may originate from the dysbiotic salivary microbiota and cause the onset of schizophrenia through the peripheral inflammatory response and redox system, suggesting the importance of oral-brain connection in the pathogenesis of schizophrenia. FAU - Cui, Gaoping AU - Cui G AD - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 200030, China. FAU - Qing, Ying AU - Qing Y AUID- ORCID: 0000-0001-5846-9248 AD - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 200030, China. FAU - Li, Minghui AU - Li M AD - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 200030, China. FAU - Sun, Liya AU - Sun L AD - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 200030, China. FAU - Zhang, Juan AU - Zhang J AD - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 200030, China. FAU - Feng, Lei AU - Feng L AD - Instrumental Analysis Center, Shanghai Jiao Tong University, Shanghai 200240, China. FAU - Li, Jing AU - Li J AUID- ORCID: 0000-0003-4602-3227 AD - Department of Bioinformatics and Biostatistics, Shanghai Jiao Tong University, Shanghai 200240, China. FAU - Chen, Tianlu AU - Chen T AUID- ORCID: 0000-0003-1798-5435 AD - Shanghai Key Laboratory of Diabetes Mellitus and Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China. FAU - Wang, Jijun AU - Wang J AD - Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Psychotic Disorders, Shanghai 200030, China. FAU - Wan, Chunling AU - Wan C AUID- ORCID: 0000-0002-0372-0041 AD - Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 200030, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20211007 PL - United States TA - J Proteome Res JT - Journal of proteome research JID - 101128775 RN - 0 (Biomarkers) SB - IM MH - Biomarkers MH - Humans MH - Mass Spectrometry MH - Metabolomics/methods MH - Prodromal Symptoms MH - *Psychotic Disorders MH - *Schizophrenia/diagnosis/metabolism OTO - NOTNLM OT - aromatic amino acid metabolism OT - clinical high risk of psychosis OT - glutamine and nucleotide metabolism OT - metabolomics OT - schizophrenia OT - tricarboxylic acid cycle EDAT- 2021/10/08 06:00 MHDA- 2022/02/26 06:00 CRDT- 2021/10/07 17:13 PHST- 2021/10/08 06:00 [pubmed] PHST- 2022/02/26 06:00 [medline] PHST- 2021/10/07 17:13 [entrez] AID - 10.1021/acs.jproteome.1c00504 [doi] PST - ppublish SO - J Proteome Res. 2021 Nov 5;20(11):5010-5023. doi: 10.1021/acs.jproteome.1c00504. Epub 2021 Oct 7.